First Time Loading...

Eyebright Medical Technology Beijing Co Ltd
SSE:688050

Watchlist Manager
Eyebright Medical Technology Beijing Co Ltd Logo
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Watchlist
Price: 75.58 CNY -1.55%
Updated: Jun 11, 2024

Eyebright Medical Technology Beijing Co Ltd
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eyebright Medical Technology Beijing Co Ltd
Cash from Investing Activities Peer Comparison

Comparables:
1066
S
600529
603658
300888
300832

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Cash from Investing Activities
-¥307.8m
CAGR 3-Years
N/A
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Cash from Investing Activities
-¥1.4B
CAGR 3-Years
N/A
CAGR 5-Years
26%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Cash from Investing Activities
-¥1B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-20%
Autobio Diagnostics Co Ltd
SSE:603658
Cash from Investing Activities
-¥822.5m
CAGR 3-Years
35%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Cash from Investing Activities
¥1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Cash from Investing Activities
-¥290.7m
CAGR 3-Years
51%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is Eyebright Medical Technology Beijing Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-307.8m CNY

Based on the financial report for Dec 31, 2022, Eyebright Medical Technology Beijing Co Ltd's Cash from Investing Activities amounts to -307.8m CNY.

What is Eyebright Medical Technology Beijing Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-56%

Over the last year, the Cash from Investing Activities growth was 27%.